Defined as knee stiffness after TKA, usually 10° extension loss. Incidence: 3–6% after TKA. Causes: poor rehab, malposition, infection, scar tissue formation. Management: early manipulation under anesthesia (MUA), arthrolysis, revision if mechanical cause. Prevention: adequate pain control, early physiotherapy, correct alignment.
What is the primary definition of arthrofibrosis following total knee arthroplasty (TKA)?
What is the estimated incidence of arthrofibrosis after total knee arthroplasty?
Which of the following is NOT a recognized cause of arthrofibrosis after TKA?
What is the most effective strategy for preventing arthrofibrosis after TKA?
Infrapatellar contracture syndrome (IPCS) is characterized by which of the following?
Which cytokine is primarily involved in the pathophysiology of arthrofibrosis?
What is a common risk factor for developing arthrofibrosis following TKA?
What is the role of manipulation under anesthesia (MUA) in the management of arthrofibrosis?
What is a potential consequence of inadequate post-operative analgesia in TKA patients?
Which of the following is a method to assess and balance flexion and extension gaps intraoperatively during TKA?
